The goal of the second of the three phases of human clinical trials is
A) the development of methods for the efficient synthesis of the drug.
B) identifying the most effective doses and schedules of treatment.
C) testing with animal models.
D) screening for safety.
E) demonstrating that the drug is clinically effective.
Question 2
The final phase of human clinical trials usually involves
A) placebo controls.
B) double-blind procedures.
C) yoked controls.
D) all of the above
E) both A and B